Statistics for Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer
Total visits
| views | |
|---|---|
| Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer | 3 |
Total visits per month
| views | |
|---|---|
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:21c8055c-97b5-49ec-86bb-fccf5eb610a6 | 63 |
| nihms-1809275.pdf | 25 |
| java.util.UUID:a39fea5b-8cb3-4932-83a8-ffb4ff8b1553 | 7 |
| java.util.UUID:b508c5b1-2714-4bb6-964e-123b6c9ec7fb | 7 |
Top country views
| views | |
|---|---|
| United States | 3 |
Top city views
| views | |
|---|---|
| Franklin | 2 |
| Indianapolis | 1 |